Discover 1,407 paid clinical trials in Kent, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,407
Featured
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
for
Bipolar Depression
Location: 35 recruiting locations
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 10 - 17
Code: NCT06372964
Phase3, Recruiting
Active & ResponsiveNew
Study of Healthy Aging and Physical Function With Elamipretide
for
Aging, Healthy
Location: 1 recruiting location
Sponsor: David Marcinek
Sex: All
Age: 65 - 70+
Code: NCT07275424
Phase2, Recruiting
Active & ResponsiveNew
Development of a Quantifiable Ultrasound Biomarker for Hepatic Steatosis
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
for
Metastatic Non-small Cell Lung Cancer
Location: 34 recruiting locations
Sponsor: NovoCure GmbH
Sex: All
Age: 18+
Code: NCT06216301
Phase3, Recruiting
Active & Responsive
Assessment of Early Pregnancy MAB Completion
for
Pregnancy, Abortion Early
Location: 3 recruiting locations
Sponsor: University of Washington
Sex: Female
Age: 0+
Code: NCT06893484
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
National Cancer Institute "Cancer Moonshot Biobank"
for
Acute Myeloid Leukemia,
Location: 113 recruiting locations
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 13+
Code: NCT04314401
Recruiting
Active & Responsive
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
for
Psoriasis, Overweight or Obesity
Location: 42 recruiting locations
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06857942
Recruiting
Active & Responsive
A Trial Evaluating Efficacy of AGA2118 in PostMenopausal Women wIth Low Bone MasS (ARTEMIS)
for
Postmenopausal Osteoporosis
Location: 5 recruiting locations
Sponsor: Angitia Biopharmaceuticals
Sex: Female
Age: 55 - 70+
Code: NCT06577935
Phase2, Recruiting
Active & Responsive
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
for
Treatment Resistant Depression
Location: 51 recruiting locations
Sponsor: LivaNova
Sex: All
Age: 18+
Code: NCT03887715
Recruiting
Active & Responsive
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab